Applications of 2-(4-Pyridil)-5,5-Dimethyl-1,3,2-Dioxaboronane in Industrial Manufacturing

As an established producer of 2-(4-pyridil)-5,5-dimethyl-1,3,2-dioxaboronane, we supply this boronate ester to downstream manufacturers advancing specialized synthesis across pharmaceutical, agrochemical, OLED material, and fine chemical industries. Our product meets stringent quality benchmarks, supporting consistently reliable performance at each stage of the customer manufacturing chain. Below, we detail how our material integrates into specific industrial applications, providing process and regulatory details for technical decision-makers.

1. Pharmaceutical Intermediate Synthesis: Suzuki Coupling Reactions

Process chemists in pharmaceutical API production use this boronate ester as a coupling partner in Suzuki–Miyaura cross-coupling to build complex, drug-relevant biaryl and heteroaryl structures. It supports scalable manufacturing of advanced intermediates for targeted therapies, where regulatory and analytical clarity are critical for cGMP compliance and supporting ANDA/DMF submissions.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 211 (cGMP for finished pharmaceuticals)
• USP General Chapters for Residual Solvents and Impurities
• European Pharmacopoeia (Ph. Eur.) guidelines for APIs and intermediates

Typical usage ratio

• 0.95–1.10 molar equivalents relative to the electrophilic aryl halide substrate, adjusted for conversion rate and impurity control in each scale-up campaign

Downstream process integration

• Charged into catalyst-driven Suzuki–Miyaura reaction vessel after solvent conditioning; reacts with aryl or heteroaryl halide under nitrogen atmosphere; typically isolated via aqueous workup and crystallization prior to downstream derivatization

Final product types

• Key intermediates for small molecule APIs targeting oncology, CNS, and antiviral therapeutics
• Building blocks for advanced clinical candidate molecules
• Research compounds utilized in medicinal chemistry departments

2. Electronic Materials: OLED Emissive Layer Component Synthesis

In OLED material R&D and production, manufacturers employ this molecule as a boron source for constructing pyridine-functionalized boron complexes, which are applied in the synthesis of blue and green emitters. Precise incorporation allows for tuning photophysical properties of emissive layers, supporting device longevity and high color purity requirements set by electronics OEMs.

Industry compliance standards

• IEC 62341 standards for OLED display performance and lifetime
• RoHS Directive 2011/65/EU (Restriction of Hazardous Substances for electronic components)
• ISO 9001:2015 Quality Management System for electronic materials manufacturing

Typical usage ratio

• 0.5–2.0 wt% in pre-polymerization feed for boron-based complex synthesis, precisely controlled according to emission wavelength and film stability testing

Downstream process integration

• Introduced to reaction stage for ligand exchange and boron complexation after purification steps; end-use materials formulated as spin-coatable or evaporative layers during device assembly

Final product types

• OLED display and lighting panels
• Organic electronic substrates for mobile phones, TVs, and lighting modules
• Custom emissive layer dopants for next-generation optoelectronic devices

3. Agrochemical Active Ingredient Synthesis

Manufacturers of crop protection compounds leverage this boronate in catalytic cross-coupling steps to assemble key heterocyclic motifs found in advanced herbicide, fungicide, and insecticide active ingredients. The high stereochemical purity supports strict residue testing and registration standards across major markets.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS)
• ISO 17025 (Quality for analytical laboratories supporting regulatory dossiers)
• REACH Regulation (EC) No 1907/2006 for agrochemical chemical hazard management
• EPA Title 40 CFR (US pesticide registration)

Typical usage ratio

• 1.00 molar equivalent relative to aryl halide building block, modified by specific stoichiometry for process impurity suppression during scale-up

Downstream process integration

• Dosed into inerted batch reactors at cross-coupling stage; after completion and workup, the synthesized intermediate proceeds to downstream formulation with co-active agents or formulation adjuvants

Final product types

• Technical grade agrochemical actives for herbicides and fungicides
• Formulated crop protection products for row crops and specialty agriculture
• Intermediates for patent-portfolio agricultural technology

4. Fine Chemicals: Ligand or Catalyst Synthesis for Organic Transformation

Producers of fine chemical catalysts and ligands integrate this intermediate in the assembly of boron-containing pyridyl ligands. These ligands serve as key performance components in homogeneous catalysis and organometallic transformations employed in custom manufacturing and research-scale synthesis.

Industry compliance standards

• ISO 9001:2015 for fine chemical production and quality control
• European REACH compliance for laboratory and industrial chemicals
• Responsible Care® Management Systems

Typical usage ratio

• Varies from 0.2 to 1.5 molar equivalents per ligand synthesis route, set by desired ligand architecture and metal-to-ligand ratio in the final catalyst design

Downstream process integration

• Added post-activation step in ligand assembly; reacted with pre-functionalized pyridine moieties under controlled temperature and inert atmosphere; products isolated and purified for downstream catalyst formulation

Final product types

• Boron-functionalized ligands for homogeneous catalysis
• Pyridyl boron catalyst systems for pharmaceutical and industrial organic transformations
• Laboratory reagents for academic and industrial R&D